Education
About Us
Working with TipRanks
Follow Us
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
JUBLPHARMA Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
JUBLPHARMA Stock 12 Month Forecast
Average Price Target
₹1,385.00
▲(17.89%Upside)
| Highest Price Target₹1,385 | Average Price Target₹1,385 | Lowest Price Target₹1,385 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
₹1,278
Hold
8.78%
Upside
07/08/25
Jubilant Pharmova Limited's overall score is driven primarily by solid technical momentum and stable financial performance, tempered by concerns over cash flow management and a potentially high valuation. The lack of earnings call data and corporate events means these factors did not influence the score.
Nuvama
₹1,385
Buy
17.89%
Upside
Reiterated
06/27/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
₹1,278
Hold
8.78%
Upside
07/08/25
Jubilant Pharmova Limited's overall score is driven primarily by solid technical momentum and stable financial performance, tempered by concerns over cash flow management and a potentially high valuation. The lack of earnings call data and corporate events means these factors did not influence the score.
Nuvama
₹1,385
Buy
17.89%
Upside
Reiterated
06/27/25
Best Analysts Covering Jubilant Pharmova Limited
1 Month
xxx
Success Rate
1/1 ratings generated profit
Average Return
+5.20%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +5.20% per trade.
3 Months
xxx
Success Rate
1/1 ratings generated profit
Average Return
+5.20%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.20% per trade.
1 Year
Success Rate
0/1 ratings generated profit
Average Return
0.00%
reiterated a buy rating last month
Copying Shrikant Akolkar's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
Average Return
+5.20%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +5.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
JUBLPHARMA Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Strong Buy
0
0
Buy
1
1
Hold
0
2
Sell
0
0
Strong Sell
0
0
total
1
3
Each month's total comprises the sum of three months' worth of ratings.
JUBLPHARMA Financial Forecast
JUBLPHARMA Stock Forecast FAQ
What is IN:JUBLPHARMA’s average 12-month price target, according to analysts?
Based on analyst ratings, Jubilant Pharmova Limited’s 12-month average price target is 1,385.00.
What is IN:JUBLPHARMA’s upside potential, based on the analysts’ average price target?
Jubilant Pharmova Limited has 17.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Jubilant Pharmova Limited a Buy, Sell or Hold?
Jubilant Pharmova Limited has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Jubilant Pharmova Limited’s share price target?
The average share price target for Jubilant Pharmova Limited is 1,385.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,385.00 ,and the lowest forecast is ₹1,385.00. The average share price target represents 17.89% Increase from the current price of ₹1,174.85.
The highest analyst share price target is ₹1,385.00 ,and the lowest forecast is ₹1,385.00. The average share price target represents 17.89% Increase from the current price of ₹1,174.85.
What do analysts say about Jubilant Pharmova Limited?
Jubilant Pharmova Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Jubilant Pharmova Limited?
To buy shares of IN:JUBLPHARMA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.